A cell‐based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models

Abstract

We have extended to the H7 subtype the finding that protective efficacy may not be directly correlated with the pre-challenge levels of serum antibodies, a finding which could be of great importance in assessing the potential effectiveness of pandemic influenza vaccines.